| Literature DB >> 23301495 |
Steven E Patterson1, Alexandre R Monteil, Jonathan F Cohen, Daune L Crankshaw, Robert Vince, Herbert T Nagasawa.
Abstract
Current cyanide antidotes are administered by IV infusion, which is suboptimal for mass casualties. Therefore, in a cyanide disaster, intramuscular (IM) injectable antidotes would be more appropriate. We report the discovery of the highly water-soluble sulfanegen triethanolamine as a promising lead for development as an IM injectable cyanide antidote.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23301495 PMCID: PMC3575131 DOI: 10.1021/jm301633x
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446